Intra-cellular therapies to present at the svb securities global biopharma conference

New york, feb. 08, 2023 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that sharon mates, ph.d., chief executive officer and chairman, is scheduled to present at the svb securities global biopharma conference on wednesday, february 15, 2023 at 10:40 a.m. et.
ITCI Ratings Summary
ITCI Quant Ranking